The first Influencer Seminar will be on October 24th with Dr. Michael Longaker from Stanford University. Register today. @SpauldingMSK docs.google.com/forms/d/e/1FAI…
HSCI
@harvardstemcell
Harvard Stem Cell Institute: 1000 scientists, one goal: discovering cures. Cover image of beta cells, courtesy of the Melton laboratory
547 Following 5.1K Followers 1.5K Posts
Latest posts 5
Applications for the 2024 HSCI #internship program close February 7th. Learn more and share widely with your networks. hsci.harvard.edu/research/hsci-…
Join @BCHStemCell on October 17th for their RNA Biology and Disease Symposium! Register today: eventbrite.com/e/rna-biology-…
www.eventbrite.com RNA Biology and Disease Symposium Learn more about the latest research developments in linking RNA pathways to disease and emerging therapeutics. Congratulations to HSCI Principal Faculty @karalmckinley for being named a @HHMINEWS Freeman Hrabowski Scholar! #FHScholars news.harvard.edu/gazette/story/…
news.harvard.edu Three Harvard faculty among 31 inaugural Freeman Hrabowski Scholars Three Harvard University faculty — Kizzmekia S. Corbett, Josefina del Mármol, and Kara L. McKinley — are among 31 new Freeman Hrabowski Scholars selected from across the U.S. by the… New research from HSCI principal faculty Benjamin Ebert finds that clonal hematopoiesis of indeterminate potential (CHIP) doubles a person’s risk of chronic #liverdisease. @broadinstitute @harvardmed broadinstitute.org/news/researche…
www.broadinstitute.org Researchers discover new risk factor for liver disease A blood disorder increasingly common in older ages, called clonal hematopoiesis of indeterminate potential (CHIP), doubles a person’s risk of chronic liver disease.